Allcyte and Boehringer to characterize cancer compounds

Last month, Allcyte said it partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to use Allcyte's Pharmacoscopy ex vivo drug response profiling platform to characterize Boehringer cancer com...